We are pleased to announce that Dobson | DaVanzo was recently awarded the Part D Formulary and Benefits Assessments contract with the Centers for Medicare and Medicaid Services (CMS).

A key aim of this work is to determine whether the Part D formulary and benefit offerings are being administered as approved by Title I of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA). The addition of this drug benefit to Medicare represents a landmark change to the Medicare program that significantly improved the health care coverage available to millions of Medicare beneficiaries.

Dobson | DaVanzo, together with our subcontractor, Acumen, LLC, look forward to supporting CMS in this important work through monitoring and performing oversight analyses for the Medicare Part D program.